240 Participants Needed

Exercise for Chronic Pediatric Conditions

(Project REACH Trial)

PH
Overseen ByPeter Horvath, Ph.D.
Age: < 18
Sex: Any
Trial Phase: Academic
Sponsor: University of California, Irvine
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 1 JurisdictionThis treatment is already approved in other countries

Trial Summary

What is the purpose of this trial?

This study is a cooperative investigation funded by the NIH. The project is a collaboration among three major NIH Clinical Translational Science Awardees: 1) UCI (lead site with its affiliate CHOC), 2) Northwestern University (with its affiliate Lurie Children's Hospital), and 3) USC (with its affiliate Children's Hospital of Los Angeles). There is an increasing number of children who, through medical advances, now survive diseases and conditions that were once fatal, but which remain chronic and debilitating. A major challenge to improve both the immediate and long term care and health of such children has been the gap in our understanding of how to assess the biological effects of exercise. Like otherwise healthy children, children with chronic diseases and disabilities want to be physically active. The challenge is to determine what constitutes safe and beneficial level of physical activity when the underlying disease or condition \[e.g., cystic fibrosis (CF) or sickle cell disease (SCD)\] imposes physiological constraints on exercise that are not present in otherwise healthy children. Current exercise testing protocols were based on studies of athletes and high performing healthy individuals and were designed to test limits of performance at very high-intensity, unphysiological, maximal effort. These approaches are not optimal for children and adolescents with disease and disability. This project (REACH-Revamping Exercise Assessment in Child Health) is designed to address this gap. Cohorts of children will be identified with two major genetic diseases (CF and SCD) and measure exercise responses annually as they progress from early puberty to mid or late puberty over a 3-4year period. In addition, in the light of the pandemic, a group of children will be added who were affected by SARS-CoV-2 and investigate their responses to exercise. SARS-CoV-2 has similar long-term symptoms than CF and SCD have. Novel approaches to assessing physiological responses to exercise using advanced data analytics will be examined in relation to metrics of habitual physical activity, circulating biomarkers of inflammation and growth, leukocyte gene expression, and the impact of the underlying CF, SCD or SARS-CoV-2 condition. The data from this study will help to develop a toolkit of innovative metrics for exercise testing that will be made available to the research and clinical community.

Will I have to stop taking my current medications?

The trial does not specify if you need to stop taking your current medications, but it mentions that chronic medication use is an exclusion criterion for healthy controls and those with a history of SARS-CoV-2 infection. It's best to discuss your specific medications with the trial coordinators.

What data supports the effectiveness of the treatment Exercise, Physical Activity, Workout, Fitness Training for chronic pediatric conditions?

Research shows that exercise can improve fitness levels and muscle strength in children with chronic conditions. For example, a study found that setting specific fitness goals led to significant improvements in cardiorespiratory fitness and strength in children at risk of metabolic issues. Additionally, tailored exercise interventions have been shown to enhance exercise capacity, endurance, and quality of life in children with various chronic diseases.12345

Is exercise safe for children with chronic conditions?

Exercise is generally safe for children, including those with chronic conditions like congenital heart disease, when done appropriately. Studies show that exercise can help improve physical fitness and is recommended by health authorities, but it's important to follow specific guidelines and consult with healthcare providers.678910

How is exercise different from other treatments for chronic pediatric conditions?

Exercise is unique because it not only helps alleviate symptoms of chronic conditions but also improves a child's overall quality of life and psychosocial development. Unlike medications, exercise can enhance physical fitness, reduce body fat, and improve functional ability, making it a holistic approach to managing chronic diseases in children.1112131415

Eligibility Criteria

Children aged approximately 10-17 with cystic fibrosis, sickle cell disease, or past SARS-CoV-2 infection are eligible for this exercise study if they're in good health and have no other conditions that limit physical activity. They must be at a stage of puberty as defined by Tanner stages 1-5 and have physician approval to perform exercise tests.

Inclusion Criteria

I have sickle cell disease and am between 10 to 17 years old.
I have been diagnosed with Cystic Fibrosis based on genetic tests or sweat chloride levels.
I am between 10 and 17 years old.
See 15 more

Exclusion Criteria

I am receiving treatment for substance or alcohol abuse, or I use chronic medication.
PERC staff will decide if you are not fit for exercise because of SARS-CoV-2.
I have cystic fibrosis and am currently infected with either Burkholderia cenocepacia or Mycobacterium abscessus.
See 7 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants undergo Cardiopulmonary Exercise Test (CPET) to measure cardiorespiratory responses, with blood sampling at multiple time points

8 months
Annual visits for exercise testing and blood sampling

Follow-up

Participants are monitored for safety and effectiveness after treatment, including gene expression and body composition assessments

8 months

Treatment Details

Interventions

  • Exercise
Trial Overview The REACH project is testing how children with chronic diseases respond to exercise. It aims to develop new ways of measuring the effects of physical activity on kids with genetic diseases like cystic fibrosis and sickle cell disease, as well as those affected by COVID-19.
Participant Groups
4Treatment groups
Experimental Treatment
Active Control
Group I: Children With Sickle Cell Disease (SCD)Experimental Treatment1 Intervention
Cardiopulmonary Exercise Test (CPET) will be performed to measure cardiorespiratory responses in children with Children With Sickle Cell Disease (SCD). Exercise will consist of up to 8, 2 minutes bouts of constant work rate cycle ergometry with 1 minute resting intervals between each exercise bout. A subgroup of children will be asked to allow the investigators to obtain blood samples during the exercise session. The following procedures will occur: * The child will be in a fasted state. * An IV will be placed into the child's arm. * Blood sampling will be taken at 4 time points; baseline, and the end of exercise, and at 30 and 60 minutes post exercise.
Group II: Children With Documented History of SARS CoV-2 InfectionExperimental Treatment1 Intervention
Cardiopulmonary Exercise Test (CPET) will be performed to measure cardiorespiratory responses in children with a documented history of SARS CoV-2 Infection. Exercise will consist of up to 8, 2 minutes bouts of constant work rate cycle ergometry with 1 minute resting intervals between each exercise bout. A subgroup of children will be asked to allow the investigators to obtain blood samples during the exercise session. The following procedures will occur: * The child will be in a fasted state. * An IV will be placed into the child's arm. * Blood sampling will be taken at 4 time points; baseline, and the end of exercise, and at 30 and 60 minutes post exercise.
Group III: Children With Cystic Fibrosis (CF)Experimental Treatment1 Intervention
Cardiopulmonary Exercise Test (CPET) will be performed to measure cardiorespiratory responses in children with Children With Cystic Fibrosis (CF). Exercise will consist of up to 8, 2 minutes bouts of constant work rate cycle ergometry with 1 minute resting intervals between each exercise bout. A subgroup of children will be asked to allow the investigators to obtain blood samples during the exercise session. The following procedures will occur: * The child will be in a fasted state. * An IV will be placed into the child's arm. * Blood sampling will be taken at 4 time points; baseline, and the end of exercise, and at 30 and 60 minutes post exercise.
Group IV: Healthy ControlsActive Control1 Intervention
Cardiopulmonary Exercise Test (CPET) will be performed to measure cardiorespiratory responses in healthy controls. Exercise will consist of up to 8, 2 minutes bouts of constant work rate cycle ergometry with 1 minute resting intervals between each exercise bout. A subgroup of children will be asked to allow the investigators to obtain blood samples during the exercise session. The following procedures will occur: * The child will be in a fasted state. * An IV will be placed into the child's arm. * Blood sampling will be taken at 4 time points; baseline, and the end of exercise, and at 30 and 60 minutes post exercise.

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of California, Irvine

Lead Sponsor

Trials
580
Recruited
4,943,000+

Children's Hospital of Orange County

Collaborator

Trials
38
Recruited
5,700+

Children's Hospital Los Angeles

Collaborator

Trials
257
Recruited
5,075,000+

Ann & Robert H Lurie Children's Hospital of Chicago

Collaborator

Trials
275
Recruited
5,182,000+

Children's Hospital of Orange County (CHOC)

Collaborator

Trials
1
Recruited
240+

Children's Hospital of Los Angeles (CHLA)

Collaborator

Trials
2
Recruited
3,600+

Lurie Children's Hospital in Chicago

Collaborator

Trials
1
Recruited
240+

Findings from Research

A randomized controlled trial is being conducted to evaluate the effectiveness of a live-video-supervised exercise program for pediatric Fontan patients, aiming to improve their cardiac and physical capacity, muscle mass, strength, and endothelial function.
This innovative approach addresses the low adherence rates seen in traditional exercise interventions by using technology to provide supervised sessions, with the goal of reducing long-term morbidity and mortality in these patients.
Design and rationale of re-energize fontan: Randomized exercise intervention designed to maximize fitness in fontan patients.Selamet Tierney, ES., Palaniappan, L., Leonard, M., et al.[2023]
The Fitkids program included 2482 children with diverse demographics and medical diagnoses, highlighting the varied needs of children with chronic conditions or disabilities.
Participants showed significantly reduced aerobic fitness levels, as indicated by poor performance on the 6-minute walk test and half Bruce treadmill test, suggesting a need for targeted interventions to improve their fitness.
Fitkids exercise therapy program in the Netherlands.Kotte, EM., Winkler, AM., Takken, T.[2019]
Fitness testing in pediatric practice was successfully implemented with 580 participants, measuring cardiorespiratory fitness, strength, and flexibility, showing that it is feasible and effective.
Setting SMART goals led to significant improvements in cardiorespiratory fitness (11.9%) and strength (12.4%) in children at high risk for metabolic issues, although body mass index changes were not significantly affected.
Short-Term Impact of Exercise Fitness Testing in a Pediatric Metabolic and Obesity Clinic: Initiative to Improve Health Care Quality.Vincent, HK., Bhavsar, P., Bernier, A.[2023]

References

Design and rationale of re-energize fontan: Randomized exercise intervention designed to maximize fitness in fontan patients. [2023]
Fitkids exercise therapy program in the Netherlands. [2019]
Short-Term Impact of Exercise Fitness Testing in a Pediatric Metabolic and Obesity Clinic: Initiative to Improve Health Care Quality. [2023]
Training of aerobic and anaerobic fitness in children with asthma. [2022]
Study Protocol of the Exercise Study: Unraveling Limitations for Physical Activity in Children With Chronic Diseases in Order to Target Them With Tailored Interventions-A Randomized Cross Over Trial. [2022]
Safety and efficacy of exercise training in children and adolescents with congenital heart disease: A systematic review and descriptive analysis. [2023]
Pediatric exercise: truth and/or consequences. [2018]
Postoperative exercise training develops normal levels of physical activity in a group of children following cardiac surgery. [2018]
Strength training by children and adolescents. [2019]
A survey of exercise advice and recommendations in United Kingdom paediatric cardiac clinics. [2018]
Effects of exercise training on physical and psychosocial health in children with chronic respiratory disease: a systematic review and meta-analysis. [2023]
12.United Statespubmed.ncbi.nlm.nih.gov
Physical activity recommendations for children and adolescents with chronic disease. [2022]
Children, Sports, and Chronic Disease. [2016]
14.United Statespubmed.ncbi.nlm.nih.gov
Inclusion of resistance exercise in a multidisciplinary outpatient treatment program for preadolescent obese children. [2019]
15.United Statespubmed.ncbi.nlm.nih.gov
Physical activity recommendations for children with specific chronic health conditions: juvenile idiopathic arthritis, hemophilia, asthma, and cystic fibrosis. [2022]